Cite
HARVARD Citation
Usul Afsar, Ç. et al. (n.d.). Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma. Journal of infection and chemotherapy. 23 (4), pp. 196-200. [Online].